Share on StockTwits

Dentsply International (NASDAQ:XRAY) was upgraded by Barrington Research from a “market perform” rating to an “outperform” rating in a research note issued on Friday, TheFlyOnTheWall.com reports.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Dentsply International in a research note on Wednesday, May 7th. They now have a $48.00 price target on the stock. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Dentsply International presently has a consensus rating of “Buy” and an average target price of $50.75.

In other Dentsply International news, VP Robert Size sold 5,049 shares of the stock on the open market in a transaction dated Monday, May 12th. The shares were sold at an average price of $46.29, for a total transaction of $233,718.21. Following the sale, the vice president now directly owns 11,588 shares of the company’s stock, valued at approximately $536,409. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Dentsply International (NASDAQ:XRAY) opened at 45.96 on Friday. Dentsply International has a 52 week low of $39.90 and a 52 week high of $50.99. The stock’s 50-day moving average is $45.56 and its 200-day moving average is $46.5. The company has a market cap of $6.517 billion and a P/E ratio of 21.27.

Dentsply International (NASDAQ:XRAY) last announced its earnings results on Tuesday, May 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.03. The company had revenue of $730.10 million for the quarter, compared to the consensus estimate of $747.27 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was down .3% on a year-over-year basis. Analysts expect that Dentsply International will post $2.52 EPS for the current fiscal year.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.